Skip to content

Immix Biopharma, Inc. IMMX Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

AbbVie logo
AbbVieABBV
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s treasury stock, shares (in shares)?
Immix Biopharma, Inc. (IMMX) reported treasury stock, shares (in shares) of $72.36K in Q1 2026.
How has Immix Biopharma, Inc.'s treasury stock, shares (in shares) changed year-over-year?
Immix Biopharma, Inc.'s treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $72.36K to $72.36K.
What is the long-term trend for Immix Biopharma, Inc.'s treasury stock, shares (in shares)?
Over 3 years (2022 to 2025), Immix Biopharma, Inc.'s treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $72.36K to $72.36K.